# Bioequivalence Study of Amlodipine Tablets Under Fasting Conditions

> **NCT00775905** · NA · COMPLETED · sponsor: **Ranbaxy Laboratories Limited** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** amlodipine 10 mg tablet

## Key facts

- **NCT ID:** NCT00775905
- **Lead sponsor:** Ranbaxy Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2005-08
- **Final completion:** 2005-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2008-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00775905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00775905, "Bioequivalence Study of Amlodipine Tablets Under Fasting Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00775905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*